E-DRUG: US FDA may impose huge drug user fee on generic imports
------------------------------------------------
Dear Colleagues:
Below follows news of measures by the US Congress to levy considerable fees
on the importation of generic medicines. The proposed Act will most likely
lead to reduced generic medicine competition resulting in artificially high
generic medicine prices. However, if the US FDA improves its medicine
approval times, the fees contemplated in the Act may be offset by increased
revenue. Some generic medicine manufacturers in India and China may be
willing to pay the fees. Patients may benefit but only if it leads to
greater competition and reduced generic medicine prices.